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The motive forces for ciliary movement are generated by large multiprotein complexes referred to as outer dynein arms (ODAs), which
are preassembled in the cytoplasm prior to transport to the ciliary axonemal compartment. In humans, defects in structural
components, docking complexes, or cytoplasmic assembly factors can cause primary ciliary dyskinesia (PCD), a disorder characterized
by chronic airway disease and defects in laterality. By using combined high resolution copy-number variant and mutation analysis, we
identified ARMC4 mutations in twelve PCD individuals whose cells showed reduced numbers of ODAs and severely impaired ciliary
beating. Transient suppression in zebrafish and analysis of an ENU mouse mutant confirmed in both model organisms that ARMC4
is critical for left-right patterning. We demonstrate that ARMC4 is an axonemal protein that is necessary for proper targeting and
anchoring of ODAs.Cilia are highly organized and evolutionarily conserved
microtubule-based organelles likely composed of several
hundred proteins.1 In contrast to primary cilia, which are
likely chemosensory and are present in almost all cell
types, motile cilia generate active beating through dynein
motors and associated complexes in only certain cell types,
such as respiratory epithelium.2 In humans, mutations in
genes that comprise structural components or factors
that regulate assembly of these structural components
result in primary ciliary dyskinesia (PCD, MIM 244400).3
To date, mutations in 19 genes have been reported to cause
PCD; however, no mutations have ever described a func-
tional role for targeting these complexes.
We used copy-number variation (CNV) analysis to accel-
erate discovery of PCD-causing mutations. In contrast to
point mutations, the contribution of CNVs in ciliary
disorders is poorly defined, and large deletions have been
reported in disorders of motile cilia only on rare occa-
sions.4 To overcome this challenge, we generated a custom
high-resolution oligonucleotide array-CGH containing
probes for 772 genes prioritized from the ciliary proteome
(see Table S1 available online), which we used to screen a
cohort of 96 ciliopathy individuals. Signed and informed
consent was obtained from all participants and family
members according to protocols approved by the Institu-
tional Ethics Review Boards at the University of Muenster
and Freiburg as well as collaborating institutions.1Department of General Pediatrics, University Children’s Hospital Muenster,
University Medical Center, Durham, NC 27710, USA; 3Department of Develo
PA 15201, USA; 4Department of Pathology and Laboratory Medicine, UNC S
USA; 5Department of Molecular and Human Genetics, Baylor College of Medici
Germany; 7Department of Pathology, University of Pittsburgh School of Medi
Medicine, Chapel Hill, NC 27599, USA; 9Seattle Children’s Hospital and U
10Department of Respiratory Medicine, Concord Hospital, Concord 2139, Au
NC 27599, USA
*Correspondence: heymut.omran@ukmuenster.de
http://dx.doi.org/10.1016/j.ajhg.2013.06.009. 2013 by The American Societ
The AmerWe identified a homozygous deletion in individual
OP-589II1 (chr10: 28270060–28275320), which encom-
passed exons 4–7 of ARMC4 (NM_018076.2, Figures S1A
and S1B). This genomic variant was not present in either
229 healthy controls or in the Database of Genomic Vari-
ants. This CNV segregated with the disease status in the
PCD family OP-589 because the other affected sibling
OP-589II2 also carried the same homozygous deletion.
Cross-breakpoint PCR amplification (Figure S1C) showed
that the deletion encompassed 8.406 kb that span exons
4 through 7 of ARMC4 and is predicted to induce a pre-
mature termination, consistent with a loss-of-function
mutation.
We targeted our sequencing analyses to 135 PCD indi-
viduals with ODA defects documented by transmission
electron microscopy (TEM) and/or immunofluorescence
(IF) analysis. We found a homozygous variant c.2780T>G
predicting a p.Leu927Trp missense mutation in an evolu-
tionarily conserved region (Figure 1; Figure S2). This
variant is not present in the 1000 Genomes Database
(and PolyPhen-2 predicts altered function with a damage
score of 1.00). Additionally, we found ARMC4 homozygous
and compound heterozygous mutations in eight addi-
tional PCD families, all predicting premature termination
of translation. In total, we identified ARMC4 mutations in
12 PCD individuals from 10 families that segregated with
the disease status in an autosomal-recessive inheritance48149 Muenster, Germany; 2Center for Human Disease Modeling, Duke
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Figure 1. ARMC4 Mutations in Human PCD Individuals and in Mice
(A) Schematic of chromosome 10 and genomic structure of ARMC4. The positions of the identified mutations are indicated by black
arrows, the position of the 8.4 kb deletion is indicated by dashed lines.
(B) Schematic of the relative positions of ARMC4mutations identified in PCD individuals in the ARMC4 coding sequence. Onemutation
is a deletion, six lead to a premature stop and one is a missense mutation exchanging leucine with tryptophan at the position 927
(vertical red bar).
(C) Aotea Armc4 mutant mouse carrying the missense mutation (vertical red bar) represents methionine exchanged with lysine at the
position 993 (equivalent to human Met1000).
(D) Chest X-ray of individual OP-38II1 shows situs inversus totalis (dextrocardia, gastric bubble right, liver on the left) and left paracar-
dial opacities with cystic lesions suggestive for middle lobe atelectasis and bronchiectasis.pattern (Table S2). All affected individuals displayed
a clinical phenotype consistent with PCD including
recurrent upper and lower airway disease as well as
bronchiectasis. Seven of 12 individuals had neonatal
respiratory distress syndrome. Additionally, eight of the
12 affected individuals displayed situs inversus totalis
and four had situs solitus. All of the tested individuals
had low levels of nasal nitric oxide.5 Thus, ARMC4 defi-
ciency causes PCD and randomization of left/right body
asymmetry (Figure 1D; Table S2).
ARMC4, located on chromosome 10p12.1-p11.23,
contains 20 exons encoding a protein of 1,044 amino
acids. Although a role for ARMC4 in ciliary function has
not been reported, ARMC4 has been identified in the cilia
proteome,6 specifically in mass spectrometry studies
of human bronchial epithelium and trypanosome
flagella.7,8 Its expression profile has been inferred to pre-
dict a ciliary gene,9 and it is expressed in multiciliated
airway cells.10 Overall these data suggest an evolutionarily
conserved functional role for ciliary and flagellar motility.
ARMC4 has 10 Armadillo repeat motifs (ARMs) and one
HEAT repeat. ARM proteins are known to be involved in358 The American Journal of Human Genetics 93, 357–367, August 8a variety of processes including cell migration and prolifer-
ation, signal transduction, and maintenance of overall cell
structure. It is also reported that tandem ARM-repeat units
fold together as a superhelix, forming a versatile platform
for interactions with many protein partners.11
To test whether ARMC4 has an evolutionarily conserved
role in establishing left-right asymmetry in vertebrates, we
performed morpholino (MO)-based suppression of armc4
in zebrafish (D. rerio) embryos. Reciprocal BLAST identified
a single zebrafish armc4 ortholog (Armc4; 58% protein
sequence identity with human ARMC4). We injected two
different splice-blocking MOs into embryos at the one to
four cell stage, and embryo batches were scored subse-
quently for left-right asymmetry defects at 36 hr post-
fertilization. For each MO, we independently observed a
dose-dependent effect on heart looping, which resulted
in randomization (rightward or absent looping; Figure 2A)
at the highest doses tested due to aberrant armc4 mRNA
splicing as determined by RT-PCR (Figure S3). Coinjection
of wild-type (WT) human ARMC4mRNAwithMO resulted
in significant rescue of abnormal unlooped or rightward
looping phenotypes (56% versus 25% abnormal for WT, 2013
Figure 2. Rescue Experiments with
Human WT ARMC4 mRNA and In Vivo
Complementation Studies of ARMC4
r.2780u > g
(A) MO-induced suppression of armc4 in
zebrafish embryos gives rise to left-right
asymmetry defects. Live embryo ventral
images of cmlc2:eGFP morphants are
shown (fluorescence overlaid with bright
field). Arrows indicate heart looping
direction relative to the left (L) and right
(R) side of each embryo.
(B) Clustal alignment showing that leucine
at position 927 is evolutionary conserved
in several organisms.
(C) Quantification of live scoring of armc4
MO and human mRNA (co)injections.
cmlc2:eGFP embryos were injected with
the indicated dose (9 ng MO-2 and/or
100 pg ARMC4 mRNA) and scored live
according to criteria shown in (A). n ¼
54–116 embryos per injection, repeated
at least twice; with masked scoring; NS,
not significant; all comparisons were
made with c2 tests. To generate human
WT and r.2780u > g encoding mRNA, we
first cloned the full ARMC4 open reading
frame into the pCS2þ plasmid, linearized
with NotI, and performed in vitro
transcription with the SP6 mMessage
mMachine kit (Ambion).versus MO; p < 0.0001; n ¼ 79–116 embryos per injection;
MO-2 is shown, Figure 2C). These results confirmed a func-
tional role for armc4 in the establishment of left-right
asymmetry.
Next, to test the pathogenicity of the homozygous
c.2780T>G variant identified in the mutational screening
(Figure 2B), we compared the ability of equivalent doses
of ARMC4 WT or r.2780u > g mRNA to rescue the MO-2
induced heart looping (Figure 2C). Coinjection with MO
and ARMC4 message harboring r.2780u > g resulted in
aberrant heart looping phenotypes statistically indistin-
guishable from that of MO alone (n ¼ 54–116 embryos
per injection, scored masked for injection cocktail),
demonstrating that this variant alters protein function.
We established a forward genetic screen with N-ethyl-N-
nitrosurea (ENU) to examine defects of motile ciliary
function in the respiratory epithelium and left-right
patterning.12 All animal studies were conducted under an
Animal Study Protocol approved by the University of
Pittsburgh Animal Care and Use Committee. For mouse
whole-exome sequencing analysis, exon-capture was per-The American Journal of Human Gformed with the Agilent SureSelect
Mouse All Exon V1 kit followed
by pair-end sequencing with the
SOLiD 5500xl sequencer. Reads were
mapped to the B6 reference genome
(mm9) with LifeScope analysis tools.
Average 453 coverage was obtained,
and variants were annotated with
annovar and filtered with custom scripts. We identified a
recessive missense mutation in Armc4 (NM_001081393.1)
in the Aotea mouse line (c.T2978A/p.Met993Lys; Fig-
ure 1C). This mutation segregated consistently in homozy-
gosity among all Aotea mutants. Among homozygous
mutants with abnormal laterality, half had situs inversus
(complete reversal of heart and stomach situs, n ¼ 14)
and half exhibited heterotaxy (discordant heart and stom-
ach situs, n ¼ 13), indicating randomization of laterality
(Figure 3A; Movie S1). We performed whole-mount
in situ hybridization on mouse embryos at embryonic
day E7.5 and identified specific expression of Armc4 in
the ventral node, consistent with a role in left-right axis
development (Figure 3B). Analysis by histopathology
showed Aotea mutants can have a range of cardiovascular
anomalies, including right aortic arch, perimembranous
and muscular ventricular septal defects, ventricular non-
compaction, and anomalous venous return (Figure 3C).
Respiratory cilia of Aotea mutants were either immotile
or had slow dyskinetic motion compared to WT animals
(Movie S2). TEM analysis of tracheal airway cilia revealedenetics 93, 357–367, August 8, 2013 359
Figure 3. Armc4 Mutant Mice Aotea Display Organ Laterality Defects, Cardiac Anomalies, and Cilia Ultrastructural Defects
(A) Aotea mutant pups can exhibit situs solitus (left), heterotaxy (middle), and situs inversus totalis (right). Arrow denotes cardiac situs
with direction of heart apex orientation. Abbreviations are as follows: R, right; L, left; P, posterior; A, anterior; H, heart; S, Stomach; Sp,
Spleen.
(legend continued on next page)
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a marked reduction in ODAs (Figure 3D). High resolu-
tion IF microscopy of Aotea tracheal epithelia with
antibodies to mouse axonemal dynein heavy chain
MDNAH5 showed only proximal staining of MDNAH5,
consistent with a defect of ODA assembly in the distal
ciliary axonemes (Figure 3E). Analyses of ependymal
cilia in brain slices from the Aotea mutants revealed
that although fluid flow was generated, it was slower
than in WT animals (Movie S3). Notably, Aotea mutants
did not develop hydrocephalus during the first week of
postnatal life, which is associated commonly with
other mutant mouse models of PCD, such as Mdnah5/
mice.13 However, they develop hydrocephalus at 3 to
4 weeks of age and succumb prior to reaching reproductive
age. Overall, these findings show that this recessive
Armc4 mutation in mice causes phenotypes consistent
with PCD.
To understand further the functional role of ARMC4 in
ODA assembly, we analyzed its subcellular localization in
human motile respiratory cilia by using rabbit polyclonal
anti-ARMC4 antibodies. IF microscopy identified ARMC4
localization both within the ciliary axonemes and at the
ciliary base in control cells (Figure 4A). In respiratory cells
from individuals with ARMC4 mutations that predict pre-
mature termination of translation, ARMC4 localization
was absent from the ciliary axonemes but remained detect-
able at the ciliary base (Figures 4B–4E). The latter probably
represent nonspecific cross-reactivity to basal body pro-
teins that is observed occasionally with rabbit polyclonal
antibodies.14 We conclude that ARMC4 is an axonemal
component that is absent from the axonemes in all
individuals with loss-of-function mutations. We next
examined respiratory epithelial cells of individuals with
the ARMC4 c.2780T>G variation (Figure 4F). Here, the
axonemal ARMC4 localization was not altered, indicating
that the mutant ARMC4 still accumulated and localized
correctly.
To explore the functional consequences of ARMC4
dysfunction, we analyzed with the SAVA system the respi-
ratory ciliary beating in individuals with ARMC4 muta-(B) Whole-mount in situ hybridization analysis (performed accordin
mouse embryos (E7.5) with an Armc4 antisense probe, made from
(Invitrogen) after amplification from complementary DNA. Armc4
(E7.5) (markedwith an asterix in I) suggesting a function in left-right ax
verse section through the node. The blue precipitate shown in I and
(C) Cardiac anomalies seen in Aotea Armc4 mutant mice included
multiple muscular ventricular septal defects (mVSD), ventricular n
vena cava (IVC). Abbreviations are as follows: A, aorta; DA, ductus arte
atrium; mLV, morphological left ventricle; mRV, morphological right
cava. R, right; L, left. Scale bars in (E)–(G) are 0.5 mm and in (H) an
imaging, a Leica LSI scanning confocal microscope was used to capt
a Leica SM2500 microtome. Images were captured serially during m
3D volume rendering, the 2D image stacks were processed with Osir
(D) Aotea Armc4 mutant exhibit severe ODA defects, typically with o
showed 5–7 ODAs.
(E) Air-dried tracheal airway tissue from WT and Aotea mutant mice s
for acetylated tubulin (green) and the ODA component MDNAH5 (red
MDNAH5 localizes to the axonemes stained with acetylated tubulin (
only present in the proximal part of the ciliary axonemes (bottom r
The Amertions by high-speed videomicroscopy. Most cilia exhibited
either a markedly reduced ciliary beat frequency and
amplitude or complete immotility, consistent with severe
ODA defects (Movies S4, S5, and S6). Notably, some
c.2780T>G mutant cilia showed motility, suggesting that
more ODAs can be assembled compared to cilia of
individuals harboring ARMC4 loss-of-function mutations
(Movies S7 and S8). This indicates that the predicted
p.Leu927Trp protein present in OP-25II2 probably retains
some functionality.
Most reported PCD types are characterized by structural
defects of respiratory cilia that involve outer (ODA) and/or
inner (IDA) dynein arm components and/or function.
Genetic studies in PCD individuals to date have identified
autosomal recessivemutations ingenes encoding axonemal
structural subunitsof theODAcomplexesor relateddocking
components such as DNAH5 (MIM 603335), DNAI1 (MIM
604366), DNAI2 (MIM 605483), DNAL1 (MIM 610062),
NME8 (formally referred to as TXNDC3) (MIM 607421),
DNAH11 (MIM 603339), CCDC103 (MIM 614677), and
CCDC114 (MIM615038).15–22 In addition, mutations in
DNAAF2 (KTU) (MIM 612517), DNAAF1 (LRRC50) (MIM
613190), DNAAF3 (MIM 614566), HEATR2 (MIM 614864),
and LRRC6 (MIM 614930) encode proteins that function
in cytoplasmic preassembly of axonemal dynein arm com-
plexes and are therefore referred to as dynein axonemal
assembly factors (DNAAFs).4,23–26 Ultrastructural analysis
by TEM of respiratory ciliary axonemes from individuals
with ARMC4 mutations confirmed marked reduction of
ODAs (Figure 5G), indicating that ARMC4 deficiency or
dysfunction causes a reduction but not a complete loss of
axonemal ODA assembly. These findings are consistent
with the TEM findings observed in the Aotea Armc4mutant
mouse. Careful analyses revealed ODA abnormalities in all
analyzed cross-sections, indicating that Armc4 mutations
affect ODA composure along the entire axonemal length.
Interestingly, in c.2780T>Gmutant cilia, more ODAs than
in respiratory cilia harboring loss-of-function muta-
tions were assembled consistent with a partial loss-of-
function allele.g to standard procedures with minor modifications15) of Armc4 in
a 547 bp pCRII construct (nt 1315–1861) by TOPO TA cloning
is specifically expressed in the ventral node of mouse embryos
is development. (I), view from the left; (II), ventral view; (III), trans-
II appears gray in III as a result of the use of a gray scale camera.
mirror image dextrocardia with perimembranous (pmVSD) and
oncompaction, and anomalous venous return with dual inferior
riosus; mLA,morphological left atrium;mRA,morphological right
ventricle; LSVC, left superior vena cava; RSVC, right superior vena
d (I) are 10 mm. For EFIC (episcopic fluorescence image capture)
ure fluorescence images of the paraffin block face sectioned with
icrotome sectioning to generate registered 2D image stacks. For
ix software.
nly a few ODAs observed (blue arrows), while WT airway typically
tained by coIF and visualized by immunofluorescence microscopy
). Nuclei were stained with Hoechst 33342 (blue). In control mice,
top row), but in Aotea Armc4mutant airway epithelia, MDNAH5 is
ow).
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Figure 4. Subcellular Localization of ARMC4 in Respiratory Epithelial Cells from Individuals with PCD Carrying ARMC4 Mutations
Respiratory epithelial cells from control and PCD individuals carrying ARMC4 mutations were double-labeled with antibodies directed
against acetylated tubulin (green) and ARMC4 (red) via a rabbit polyclonal antibody (Sigma HPA037829). Nuclei were stained with
Hoechst 33342 (blue).
(legend continued on next page)
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To elucidate further the molecular defect caused by
ARMC4 deficiency, we examined the large multiprotein
ODA and IDA complexes by IF microscopy by using anti-
bodies targeting ODA (heavy chains DNAH5 and
DNAH9; intermediate chain DNAI2) and IDA (light chain
DNALI1) components. In all cases, we observed axonemal
DNALI1 localization (Figure S4) consistent with normal
IDA composition documented by TEM. In contrast,
DNAH5 and DNAI2 were present proximally but absent
distally from the ciliary axonemes, consistent with find-
ings in the Aotea Armc4 mutant mouse (Figures 5A–5D;
Figures S5A–S5F and S6A and S6B). These findings indicate
that ARMC4 mutations result in partial ODA defects in
respiratory cilia.
We have reported previously at least two discernible
ODA types in ciliary axonemes of human respiratory
cilia27—type 1 proximal compartments that contain
DNAH5 but not DNAH9, and type 2 distal compartments
that contain both DNAH5 and DNAH9. In most PCD indi-
viduals with ODA defects, both ODA types are absent from
the ciliary axonemes (e.g., mutations in DNAH5, DNAI2).
In other PCD individuals caused by mutations in genes
encoding axonemal ODA components, such as DNAI1 or
anchoring factors such as CCDC103, only type 2 ODA
complexes are affected. This is also observed for ODA
defects caused by defective cytoplasmic preassembly
involving DNAAF2 (KTU) mutations. In all of these PCD
types, the ODA heavy-chain DNAH9, which normally
localizes to the distal ODA type 2 complexes, is absent
from the ciliary axonemes (Figure S7). Thus, it was un-
expected that DNAH9 is present in the axoneme but
mislocalized throughout the whole ciliary compartment
in ARMC4 mutant cilia (Figures 5E and 5F; Figures S5G,
S5H, and S6C); the mislocalization of a structural ODA
component (DNAH9) has not been described in other
PCD types so far. This kind of ODA defect was observed
in all individuals, whether with ARMC4 truncating or
missense mutations.
Given our observation thatARMC4mutations causemis-
localization of the ODA protein DNAH9, we posited that it
is unlikely that ARMC4 represents a structural component
of ODA complexes. To test this hypothesis, we examined
ARMC4 localization in respiratory cells that carried well-
defined dynein arm defects, caused by mutations in
DNAH5 (both types 1/2 ODA defects), CCDC103 (type 2
ODA defect), and DNAAF1 (type 1/2 ODA defects and
IDA defects due to altered cytoplasmic preassembly)
(Figure S8). The axonemal localization of ARMC4
remained unaffected in all analyzed mutant cells, indi-
cating that ARMC4 is probably not a structural component
of ODA complexes. To elucidate ARMC4 function further,
we studied the axonemal localization of ARMC4 in(A) Both proteins colocalize (yellow) along the ciliary axonemes in c
(B–E) In respiratory cells of ARMC4 individuals, ARMC4 is not detecta
tion mutations that result in the failure to produce a functional ARM
phic for ARMC4 (F), ARMC4 still localizes to the ciliary axonemes. S
The AmerCCDC114 mutant cilia, and we found ARMC4 undetect-
able in these respiratory cilia (Figures 6A and 6B). Because
CCDC114 is an ODA-microtubule docking complex
component,28,29 we suggest that ARMC4 might have a
role not only in targeting but also in docking of ODA com-
plexes. On the other hand, we studied the localization of
CCDC114 in ARMC4 mutant cilia and demonstrated that
CCDC114 still localizes to the whole length of the axo-
nemes as in the unaffected controls (Figures 6C and 6D),
indicating that ODA docking complex component
CCDC114 localization is not ARMC4 dependent.
On the basis of these findings, we propose that ARMC4
belongs to a class of ciliary proteins required for correct
axonemal docking and targeting of ODA components
and/or complexes. We have previously proposed a model
for ODA assembly;23 accordingly, ARMC4 is an example
of a protein involved in a late step of axonemal ODA
assembly (step III). Interestingly, ARMC4 is not found in
the unicellular alga Chlamydomonas, a model system
classically used to study ODA assembly and in which
only a single ODA type is present.2 Our findings suggest
that ARMC4 has a unique function required for targeting
type 2 ODAs in the human and mouse airway. The identi-
fication of mutations in ARMC4 will aid the genetic
diagnosis of PCD and provide an additional model for
understanding the basic biological function of motile cilia
and flagella.Supplemental Data
Supplemental Data include eight figures, two tables, Supplemental
Grant Information, and eight movies and can be found with this
article online at http://www.cell.com/AJHG.Acknowledgments
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Figure 5. ARMC4 Mutations Result in Outer Dynein Arms (ODA) Defects of Respiratory Cilia
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